27 research outputs found
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990â2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56â604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100â000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100â000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100â000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100â000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100â000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
Droits communs deported by Germans from France occupied : repressions, representations and exclusions
Durant la Seconde guerre mondiale, prĂšs de 76 000 personnes considĂ©rĂ©es comme juives sont dĂ©portĂ©es depuis la France dans le cadre du gĂ©nocide. Plus de 66 000 autres personnes sont dĂ©portĂ©es dans les camps de concentration et prisons du Reich : des rĂ©sistants, des dĂ©tenteurs dâarme de chasse, des prostituĂ©es, des militants politiques, des individus raflĂ©s, des dĂ©tenus de droit commun, des rĂ©fractaires au travail obligatoire en Allemagne, etc. Parmi ces dĂ©portĂ©s, certains ne sont officiellement pas reconnus comme tels : ceux qui ont Ă©tĂ© arrĂȘtĂ©s, dĂ©portĂ©s suite Ă une infraction de droit commun. En effet, la loi les exclut du statut de dĂ©portĂ© et du bĂ©nĂ©fice des droits accordĂ©s aux dĂ©portĂ©s et Ă leurs proches. Cette thĂšse Ă©tudie cette exclusion, qui elle concerne, pourquoi, et comment elle se manifeste. Distinguer les dĂ©portĂ©s suite Ă une infraction de droit commun nâa rien dâune Ă©vidence car certains dĂ©lits sont propres Ă lâOccupation ainsi que les modes de rĂ©pression. De plus, parmi ceux arrĂȘtĂ©s pour une infraction de droit commun, certains sont remis aux Allemands et dĂ©portĂ©s pour une autre raison. Les tĂ©moignages dâanciens dĂ©portĂ©s Ă©voquent souvent les droit commun en se rĂ©fĂ©rant implicitement Ă un stĂ©rĂ©otype : le truand sans foi ni loi ou le kapo brutal au triangle vert. Câest finalement lâadministration qui qualifie certaines personnes comme dĂ©portĂ©es de droit commun. ConsidĂ©rĂ©es comme indignes de la reconnaissance du pays, elles ne sont alors pas reconnues comme victimes. Leur nom ne figure pas sur les monuments aux cĂŽtĂ©s des morts en dĂ©portation. Cette volontĂ© dâexclusion nâefface pas complĂštement les victimes, notamment dans les mĂ©moires familiales. Leur prĂ©sence est alors reconfigurĂ©e en fonction des reprĂ©sentations sociales.During the Second World War, around 76 000 people considered as Jews were deported from France. More than 66 000 else were sent in concentration camps and Reich prisons: rĂ©sistants, hunting gun owners, prostitutes, political activists, individuals rounded-up, droits communs, refractories from STO, etc. Among these, some were not recognized as deportees: they were arrested and put in prison after a common right offense. Indeed, law excluded them from the deportee status and the benefits related to this status. My PhD thesis deals with this exclusion, its victims, its causes, and how it took place. Nevertheless, it is not so easy to characterize people deported after a common right offense: in fact, the German administration of occupied France had its own offense system and methods of repression. Furthermore, among droits communs, some were arrested by Germans for another reasons. Former deporteesâ testimonies often evoke droits communs, referring to stereotyped representations: they describe violent gangsters or brutal kapos wearing green triangles. Finally, it is the authorities which decided to qualify people as droits communs. Considered as a shame for the Nation, they are not recognized as victims. Their names are not inscribed on war memorials. But they are still living in family memories, transformed by social representations
Senegal, a new potential endemic country for Buruli ulcer?
International audienceMycobacterium ulcerans is the causal agent of Buruli ulcer, a neglected tropical disease with cutaneous tropism. We report a case of Buruli ulcer in a patient who travelled in Senegal, a country not identified by the World Health Organization as being endemic for this disease. This case is the third case of Buruli ulcer reported as having been contracted in Senegal, showing the urgent need to develop data collection in this country by having an active community-based surveillance-response system
Sr 2 Fe 1+x Re 1âx O 6 double perovskites: magnetoresistance and (magneto)thermopower
International audiencePolycrystalline Sr2Fe1+xRe1âxO6 samples have been synthesized and structurally characterized by X-ray powder diffraction, transmission electron microscopy and X-ray absorption spectroscopy. Resistivity strongly increases with x, but a large and negative magnetoresistance persists up to x = 0.33. This is discussed considering the charge delocalization in iron and rhenium t2g orbitals
Recommended from our members
Systematic Mapping of RNA-Chromatin Interactions In Vivo
RNA molecules can attach to chromatin. It remains difficult to know what RNAs are associated with chromatin and where the genomic target loci of these RNAs are. Here, we present MARGI (mapping RNA-genome interactions), a technology to massively reveal native RNA-chromatin interactions from unperturbed cells. The gist of this technology is to ligate chromatin-associated RNAs (caRNAs) with their target genomic sequences by proximity ligation, forming RNA-DNA chimeric sequences, which are converted to a sequencing library for paired-end sequencing. Using MARGI, we produced RNA-genome interaction maps for human embryonic stem cells (ESCs) and human embryonic kidney (HEK) cells. MARGI revealed hundreds of caRNAs, including previously known XIST, SNHG1, NEAT1, and MALAT1, as well as each caRNA's genomic interaction loci. Using a cross-species experiment, we estimated that approximately 2.2% of MARGI-identified interactions were false positives. In ESCs and HEK cells, the RNA ends of more than 5% of MARGI read pairs were mapped to distal or inter-chromosomal locations as compared to the locations of their corresponding DNA ends. The majority of transcription start sites are associated with distal or inter-chromosomal caRNAs. Chromatin-immunoprecipitation-sequencing (ChIP-seq)-reported H3K27ac and H3K4me3 levels are positively correlated, while H3K9me3 is negatively correlated, with MARGI-reported RNA attachment levels. The MARGI technology should facilitate revealing novel RNA functions and their genomic target regions
VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia
International audienc
VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia
International audienc
VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia
International audienc
VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia
International audienc
VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia
International audienc